By: Benzinga
Pernix Therapeutics to Acquire Somaxon Pharmaceuticals in $25M Stock Deal
Pernix Therapeutics (NYSE: PTX ) and Somaxon Pharmaceuticals, Inc. (“Somaxon”) (NASDAQ: SOMX ) today announced that they have entered into a definitive merger agreement for Pernix to
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here